EVOK

Evoke Pharma, Inc. EVOK

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode EVOK YCBD BFRI SBFM SNOA ADIL MHUA NRSN SSKN BMRA
6M 288.69 % 82.76 % 15.33 % -7.80 % 27.27 % -2.68 % -89.48 % -62.84 % -44.78 % -15.34 %
YTD 146.09 % -51.96 % -33.94 % -58.47 % 35.82 % -77.42 % -87.06 % -28.91 % -56.36 % 9.50 %
1Y 124.95 % -44.98 % -32.71 % -57.65 % 32.36 % -77.20 % -87.30 % -35.63 % -55.75 % 1.92 %
3Y -63.33 % -98.19 % -95.76 % -99.90 % -82.06 % -95.65 % -99.43 % -34.60 % -83.86 % -90.95 %
5Y -97.09 % -99.85 % -99.18 % -99.92 % -97.76 % -99.46 % -99.65 % -79.76 % -91.91 % -92.97 %
10Y -97.76 % -99.92 % -99.18 % -100.00 % -99.65 % -99.76 % -99.65 % -79.76 % -97.73 % -72.40 %
From the beginning -99.35 % -99.92 % -99.18 % -100.00 % -99.99 % -99.76 % -99.65 % -79.76 % -99.97 % -93.69 %

Dividend